Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

Europe

Bulgarian PM reveals price for EU's new vaccine contract with Pfizer

3 minute read

Vials of the Pfizer-BioNTech Comirnaty coronavirus disease (COVID-19) vaccine are pictured in a General practitioners practice in Berlin, Germany, April 10, 2021. REUTERS/Fabrizio Bensch

Bulgarian Prime Minister Boyko Borissov has revealed that a big new vaccine supply contract that the European Union is seeking from Pfizer-BioNTech (PFE.N), (22UAy.DE) from 2022 will be at a significantly increased price.

The bloc is seeking the new supply deal with the two companies for up to 1.8 billion vaccines, of which is 900 million optional, to be delivered in 2022 and 2023, Reuters reported on Friday. read more

Borissov, speaking on Sunday, said the EU was negotiating the new contract at a price of 19.5 euros ($23.22) per dose.

"The prices are going up quickly," Borissov said during a trip to a village in southern Bulgaria.

"Pfizer's (price) was 12 euros, then increased to 15.5 euros. Now for 2022 and 2023 the European Union contracts are being signed for 900 million vaccines, but already at a price of 19.5 euros," he said.

That is a significant increase from 15.5 euros per dose the EU has paid for the 600 million Pfizer shots it has so far contracted, according to an EU internal document and officials. read more

An EU official involved in talks with vaccine makers confirmed the price cited by Borissov for the new contract but said negotiations had not been wrapped up yet.

The new contract would cover variants, meaning that the companies would offer enhanced shots if mutations of the coronavirus became prevalent, a second EU official said.

Borissov said: "Roughly this will cost 18 billion euros, at least ... That means that in the new budgets financial experts should earmark bigger, much bigger buffers for vaccines."

Borissov's government was among EU states who initially declined to buy their full share of Pfizer shots secured by the EU because they considered the vaccine too expensive, several EU officials have said.

The Balkan country of 7 million people, which has initially bet mainly on the AstraZeneca (AZN.L) vaccine, has suffered from delays and decreased deliveries of its vaccines to the EU.

At present, Sofia has vaccinated some 7.7% of its population with a first dose, the slowest rate in the EU.

Borissov said his centre-right government has secured the deliveries of some 2.7 million Pfizer doses until the middle of June that should speed up rollout and ensure herd immunity for Bulgarians.

($1 = 0.8403 euros)

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters